Loading organizations...
Key people at DealGlobe.
DealGlobe is a merchant banking and cross-border mergers and acquisitions advisory firm based in London and Shanghai that facilitates corporate transactions between Chinese and European markets. The firm operates across distinct information, advisory, and capital segments to support global financial intermediation, data processing, and hosting services. Its advisory services primarily target corporate clients operating within the business services, consumer goods, financial services, healthcare, manufacturing, and retail sectors across international borders. By combining proprietary technology with traditional investment banking expertise, the firm assists clients in navigating complex acquisitions, drawing on institutional experience from entities like Summit Partners and UBS. Operating as a registered private limited company in the United Kingdom, the firm recently filed its latest financial accounts for the period ending on December 31, 2024. DealGlobe was originally founded in 2013 by Lin Feng.
Key people at DealGlobe.
DealGlobe is a leading boutique investment bank specializing in mergers and acquisitions (M&A), with a core focus on China cross-border deals.[1][2][4] Founded in 2014 and based in London and Shanghai, it provides buyside and sellside financial advisory, structured financing, investments, and SPAC services across healthcare, TMT (technology, media, telecom), consumer, and real estate sectors, having advised on and invested in deals totaling over $6 billion.[1][2] Backed by prominent investors like Wind Information and Luolai Home, DealGlobe's philosophy emphasizes unlocking value between Chinese and Western markets through its extensive network of founders, corporates, and investors, while acting as both advisor and principal investor for better client alignment.[1][2]
Its impact on the startup and broader ecosystem stems from facilitating inbound and outbound M&A, equity investments, share-backed debt, and capital raises, particularly enabling Western companies to access Chinese buyers and helping Chinese capital enter attractive Western segments.[1][2] This dual advisory-investor model, supported by proprietary technology, enhances efficiency in late-stage VC and mid/large-cap PE deals.[1][3]
DealGlobe was founded in February 2014 by Lin Feng, a former investor at Summit Partners and banker at UBS, establishing offices in London and Shanghai to bridge China-Western markets.[1] Key milestones include the launch of DealGlobe Information in March 2015 for data services, DealGlobe Advisory in June 2015 for M&A focus, and DealGlobe Capital in November 2017 to enable direct equity participation in advised transactions.[1] The firm's evolution reflects a shift from advisory origins to a full-spectrum model incorporating technology-driven deal origination and execution, building on partners' global M&A experience from bulge-bracket banks.[1][3][5] Backed early by high-profile Chinese investors like Wind Information (China's top financial data provider) and Luolai Home (a $1B+ listed firm), DealGlobe quickly scaled to handle $6B+ in cross-border deals.[1]
DealGlobe rides the wave of intensifying China-Western capital flows amid globalization of tech, healthcare, and consumer sectors, capitalizing on market forces like China's outbound investment appetite and Western firms seeking Asian growth.[1][2] Its timing aligns with rising cross-border M&A activity, where regulatory easing and economic integration create opportunities in TMT and healthcare—areas of peak China deal volume—while addressing asymmetries in market knowledge.[1] By enabling efficient structures like investor syndicates and JV formations, DealGlobe influences the ecosystem by de-risking entries for Chinese buyers into Western assets and vice versa, fostering value creation in underserved segments and supporting tech-enabled scaling for mid/large-cap firms.[2][3]
DealGlobe is poised to expand its $6B deal pipeline amid rebounding global M&A, leveraging tech upgrades and China network for larger SPAC/PE plays in AI-driven TMT and biotech.[1][2] Trends like US-China decoupling may shift focus to neutral hubs like Europe, while sustainability and digital health could amplify its sector strengths; expect deeper LP commitments and proprietary data tools to evolve its GP role.[1][3] As cross-border barriers ease, DealGlobe's boutique agility positions it to capture outsized influence in bridging East-West value chains, solidifying its niche as the go-to for high-stakes China deals.[1][2]
